Display Settings:

Format

Send to:

Choose Destination
    Psychosomatics. 2004 May-Jun;45(3):262-70.

    Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.

    Source

    Department of Medicine, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.

    Abstract

    This column is the first in a series on HIV/AIDS antiretroviral drugs. This first review summarizes the history of HIV/AIDS and the development of highly active antiretroviral therapy (HAART) and highlights why it is important for non-HIV specialists to know about these drugs. There are four broad classes of HIV medications used in varying combinations in HAART: the protease inhibitors, nucleoside analogue reverse transcriptase inhibitors, the non-nucleoside reverse transcriptase inhibitors, and cell membrane fusion inhibitors. This paper reviews the mechanism of action, side effects, toxicities, and drug interactions of the protease inhibitors.

    PMID:
    15123854
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk